⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14040209 | 0.78 | — | — | |
| SCHEMBL10087477 | 0.67 | — | — | |
| SCHEMBL9216830 | 0.67 | — | — | |
| SCHEMBL3426947 | 0.67 | — | — | |
| SCHEMBL20530459 | 0.67 | — | — | |
| SCHEMBL14890874 | 0.67 | — | — | |
| SCHEMBL20852424 | 0.67 | — | — | |
| SCHEMBL22030300 | 0.67 | — | — | |
| SCHEMBL20530494 | 0.67 | — | — | |
| SCHEMBL20530474 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2655650-B1 | ENZYMATIC SYNTHESIS OF ACTIVE PHARMACEUTICAL INGREDIENT AND INTERMEDIATES THEREOF | LEK PHARMACEUTICALS (SI) | 2017-12-20 | — | — | EP | disclosed |
| EP-2465936-A1 | Enzymatic synthesis of statins and intermediates thereof | LEK Pharmaceuticals d.d. (SI) | 2012-06-20 | — | — | EP | disclosed |
| EP-2247739-A2 | ((2S,4R)-4,6-DIHYDROXYTETRAHYDRO-2H-PYRAN-2-YL) METHYL CARBOXYLATE AND PROCESS FOR ITS PRODUCTION EMPLOYING A 2-DEOXYRIBOSE-5-PHOSPHATE ALDOLASE | LEK Pharmaceuticals d.d. (SI) | 2010-11-10 | — | — | EP | disclosed |
| WO-2009092702-A2 | ((2S,4R)-4,6-DIHYDROXYTETRAHYDRO-2H-PYRAN-2-YL)METHYL CARBOXYLATE AND PROCESS FOR THE PRODUCTION THEREOF | LEK PHARMACEUTICALS D.D. (SI) | 2009-07-30 | — | — | WO | disclosed |